IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.
Saved in:
| Title: | IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. |
|---|---|
| Authors: | Audsley KM; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Wagner T; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Ta C; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Newnes HV; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Buzzai AC; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.; Department of Experimental Dermatology, University of Magdeburg, Magdeburg, Germany., Barnes SA; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Wylie B; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Armitage J; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Kaisho T; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan., Bosco A; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., McDonnell A; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Cruickshank M; School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australia., Fear VS; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Foley B; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Waithman J; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Sep 06; Vol. 12, pp. 735133. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34552594 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Audsley+KM%22">Audsley KM</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Wagner+T%22">Wagner T</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Ta+C%22">Ta C</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Newnes+HV%22">Newnes HV</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Buzzai+AC%22">Buzzai AC</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.; Department of Experimental Dermatology, University of Magdeburg, Magdeburg, Germany.<br /><searchLink fieldCode="AU" term="%22Barnes+SA%22">Barnes SA</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Wylie+B%22">Wylie B</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Armitage+J%22">Armitage J</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Kaisho+T%22">Kaisho T</searchLink>; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.<br /><searchLink fieldCode="AU" term="%22Bosco+A%22">Bosco A</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22McDonnell+A%22">McDonnell A</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Cruickshank+M%22">Cruickshank M</searchLink>; School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Fear+VS%22">Fear VS</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Foley+B%22">Foley B</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Waithman+J%22">Waithman J</searchLink>; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Sep 06; Vol. 12, pp. 735133. <i>Date of Electronic Publication: </i>2021 Sep 06 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34552594 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2021.735133 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 735133 Titles: – TitleFull: IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Audsley KM – PersonEntity: Name: NameFull: Wagner T – PersonEntity: Name: NameFull: Ta C – PersonEntity: Name: NameFull: Newnes HV – PersonEntity: Name: NameFull: Buzzai AC – PersonEntity: Name: NameFull: Barnes SA – PersonEntity: Name: NameFull: Wylie B – PersonEntity: Name: NameFull: Armitage J – PersonEntity: Name: NameFull: Kaisho T – PersonEntity: Name: NameFull: Bosco A – PersonEntity: Name: NameFull: McDonnell A – PersonEntity: Name: NameFull: Cruickshank M – PersonEntity: Name: NameFull: Fear VS – PersonEntity: Name: NameFull: Foley B – PersonEntity: Name: NameFull: Waithman J IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 09 Text: 2021 Sep 06 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |